Tip of the iceberg, give it a day or two for the shorts to get comfy. Small caps with strong catalysts are what traders are hungry for.
Sentiment: Strong Buy
An innovative product for a big market at a current market cap of only $20M.
EXAS, which recently got its colorectal cancer scan approved, saw its stock soar to a $2 BILLION market cap.
FDA approval of its cervical cancer scan is expected any day. Look for a triple on that date.
The Hep C market is huge.
Some 60 million pap smears are taken annually in the US.
GTHP's biophotonic scan is noninvasive, more accurate and produces instant test results.
Marketing wise, it may be huge, business wise, it is good, however all the eggs are in Honewells basket, not so good if they decide to cut and run. MBLX needs more than one large customer/partner. Lets hope there is more in the works for MBLX.
I think, and hope they can make this company work, and if not I think it has value to others.
This is a step in the right direction.
If I were short the game changers that would terrify me include
1) deep money partnership that could form a jv, build out a factory, or function as a possible owner. (Honeywell could be scary here, but others fit the bill as well)
2) MBLX had claimed it was in multiple pilots that they hoped to convert to clients by end of Q1. As I recall the to most hinted about were in different ares of pvc manufacturing. With a pretty big trade show this month in Orlando there is a chance they may want to release big news to get attention beyond Honeywell. Regardless if the pvc clients turn out to be construction siding, deck material, pipes, industrial carpet, or wire shielding...the volume requirements of the clients will be sizable. Just like Honeywell, you have to assume there is plan for production that makes sense if big clients are named.
3) speaking of which any large production plan announced changes assumptions on demand. It's been my guess that MBLX had hoped to figure out some form of larger production partnership with funding and the late highly expensive funding was a result of failing to get what they wanted done. But failure might not be a permanent result. Honeywell and a few PVC related clients of size might convince whoever I assume they were working with to move forward.
4) really wondering the size of the latex coating market could be for them. Any sales there of size change things.
Sentiment: Strong Buy